Resolute Advisors LLC Moderna, Inc. Transaction History

Resolute Advisors LLC

  • $487 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$225.82 - $368.51 $15,581 - $25,427
-69 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$221.9 - $484.47 $15,311 - $33,428
69 New
69 $27,000
Q1 2021

May 17, 2021
SELL
$109.18 - $185.98 $1,200 - $2,045
-11 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$65.74 - $169.86 $723 - $1,868
11 New
11 $1,000

Others Institutions Holding MRNA

# of Institutions
953
Shares Held
241M
Call Options Held
10.6M
Put Options Held
18.7M
View Full List

About Moderna, Inc.

MRNA Quotes by TradingView
  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $16.8B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Resolute Advisors LLC Portfolio

Follow Resolute Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Resolute Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Resolute Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email